Your browser doesn't support javascript.
loading
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Holzschuh, Julius C; Mix, Michael; Ruf, Juri; Hölscher, Tobias; Kotzerke, Jörg; Vrachimis, Alexis; Doolan, Paul; Ilhan, Harun; Marinescu, Ioana M; Spohn, Simon K B; Fechter, Tobias; Kuhn, Dejan; Bronsert, Peter; Gratzke, Christian; Grosu, Radu; Kamran, Sophia C; Heidari, Pedram; Ng, Thomas S C; Könik, Arda; Grosu, Anca-Ligia; Zamboglou, Constantinos.
Affiliation
  • Holzschuh JC; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany; Faculty of Computer Science, Karlsruhe Institute of Technology, Karlsruhe, Germany. Electronic address: julius.holzschuh@uniklinik-
  • Mix M; Department of Nuclear Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Ruf J; Department of Nuclear Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Hölscher T; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Kotzerke J; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden, Germany.
  • Vrachimis A; Department of Nuclear Medicine, German Oncology Center - University Hospital of the European University, Limassol, Cyprus.
  • Doolan P; Department of Radiation Oncology, German Oncology Center - University Hospital of the European University, Limassol, Cyprus.
  • Ilhan H; Department of Nuclear Medicine, University Hospital - Ludwig-Maximilians-Universität, Munich, Germany.
  • Marinescu IM; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Spohn SKB; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany; Faculty of Medicine - University of Freiburg, Berta-Ottenstein-Programme, Freiburg, Germany.
  • Fechter T; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany; Division of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, Freibu
  • Kuhn D; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany; Division of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, Freibu
  • Bronsert P; Department of Pathology, Medical Center - University of Freiburg, Freiburg, Germany.
  • Gratzke C; Department of Urology, Medical Center - University of Freiburg, Freiburg, Germany.
  • Grosu R; Cyber-Physical Systems Division, Institute of Computer Engineering and Faculty of Informatics, Technical University of Vienna, Vienna, Austria; Department of Computer Science, State University of New York at Stony Brook, NY, USA.
  • Kamran SC; Department of Radiation Oncology, Massachusetts General Hospital - Harvard Medical School, Boston, USA.
  • Heidari P; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital - Harvard Medical School, Department of Radiology, Boston, USA.
  • Ng TSC; Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital - Harvard Medical School, Department of Radiology, Boston, USA; Joint Program in Nuclear Medicine, Brigham and Women's Hospital - Harvard Medical School, Boston, USA; Department of Imaging, Dana-Farber Cancer Institut
  • Könik A; Joint Program in Nuclear Medicine, Brigham and Women's Hospital - Harvard Medical School, Boston, USA; Department of Imaging, Dana-Farber Cancer Institute - Harvard Medical School, Boston, USA.
  • Grosu AL; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Zamboglou C; Department of Radiation Oncology, Medical Center - University of Freiburg, Freiburg, Germany; German Oncology Center, European University of Cyprus, Limassol, Cyprus.
Radiother Oncol ; 188: 109774, 2023 11.
Article in En | MEDLINE | ID: mdl-37394103
ABSTRACT

PURPOSE:

With the increased use of focal radiation dose escalation for primary prostate cancer (PCa), accurate delineation of gross tumor volume (GTV) in prostate-specific membrane antigen PET (PSMA-PET) becomes crucial. Manual approaches are time-consuming and observer dependent. The purpose of this study was to create a deep learning model for the accurate delineation of the intraprostatic GTV in PSMA-PET.

METHODS:

A 3D U-Net was trained on 128 different 18F-PSMA-1007 PET images from three different institutions. Testing was done on 52 patients including one independent internal cohort (Freiburg n = 19) and three independent external cohorts (Dresden n = 14 18F-PSMA-1007, Boston Massachusetts General Hospital (MGH) n = 9 18F-DCFPyL-PSMA and Dana-Farber Cancer Institute (DFCI) n = 10 68Ga-PSMA-11). Expert contours were generated in consensus using a validated technique. CNN predictions were compared to expert contours using Dice similarity coefficient (DSC). Co-registered whole-mount histology was used for the internal testing cohort to assess sensitivity/specificity.

RESULTS:

Median DSCs were Freiburg 0.82 (IQR 0.73-0.88), Dresden 0.71 (IQR 0.53-0.75), MGH 0.80 (IQR 0.64-0.83) and DFCI 0.80 (IQR 0.67-0.84), respectively. Median sensitivity for CNN and expert contours were 0.88 (IQR 0.68-0.97) and 0.85 (IQR 0.75-0.88) (p = 0.40), respectively. GTV volumes did not differ significantly (p > 0.1 for all comparisons). Median specificity of 0.83 (IQR 0.57-0.97) and 0.88 (IQR 0.69-0.98) were observed for CNN and expert contours (p = 0.014), respectively. CNN prediction took 3.81 seconds on average per patient.

CONCLUSION:

The CNN was trained and tested on internal and external datasets as well as histopathology reference, achieving a fast GTV segmentation for three PSMA-PET tracers with high diagnostic accuracy comparable to manual experts.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Deep Learning Type of study: Guideline / Prognostic_studies Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Deep Learning Type of study: Guideline / Prognostic_studies Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2023 Document type: Article